Leptin-Enhanced JAK-STAT Signaling in Acute Myeloid Leukemia-Derived Mesenchymal Stromal Cells and Its Implications for Disease Progression
Muzaffar Bhatti(University Health Network), Dennis Dong Hwan Kim(University Health Network), Armand Keating(University Health Network), Amirthagowri Ambalavanan(Queen's University), Oyeronke Ayansola(Nigeria Centre for Disease Control), Troy Ketela(University of Toronto), Danielle Pyne(University Health Network), Anthea Travas(University Health Network), Jaeyoon Kim(LG (United States)), Andrea Arruda(University Health Network), Mark D. Minden(University Health Network)
Cited by 2
Related Papers
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2010|1k
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737